Kelley S - Search Results

1

A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.

Eschrich SA, Pramana J, Zhang H, Zhao H, Boulware D, Lee JH, Bloom G, Rocha-Lima C, Kelley S, Calvin DP, Yeatman TJ, Begg AC, Torres-Roca JF. Eschrich SA, et al. Among authors: kelley s. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):489-96. doi: 10.1016/j.ijrobp.2009.06.014. Int J Radiat Oncol Biol Phys. 2009. PMID: 19735873 Free PMC article. Clinical Trial.

2

Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.

Helm J, Enkemann SA, Coppola D, Barthel JS, Kelley ST, Yeatman TJ. Helm J, et al. Among authors: kelley st. Clin Cancer Res. 2005 Apr 1;11(7):2478-85. doi: 10.1158/1078-0432.CCR-04-1280. Clin Cancer Res. 2005. PMID: 15814623

3

Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways.

Kelley ST, Coppola D, Yeatman T, Marcet J. Kelley ST, et al. Clin Colorectal Cancer. 2005 Jul;5(2):114-8. doi: 10.3816/ccc.2005.n.023. Clin Colorectal Cancer. 2005. PMID: 16098252

4

Activation of the serine/threonine protein kinase Akt during the progression of Barrett neoplasia.

Sagatys E, Garrett CR, Boulware D, Kelley S, Malafa M, Cheng JQ, Sebti S, Coppola D. Sagatys E, et al. Among authors: kelley s. Hum Pathol. 2007 Oct;38(10):1526-31. doi: 10.1016/j.humpath.2007.03.003. Epub 2007 Jul 19. Hum Pathol. 2007. PMID: 17640711

5

Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utility.

Nasir A, Stridsberg M, Strosberg J, Su PH, Livingston S, Malik HA, Kelley ST, Centeno BA, Coppola D, Malafa ME, Yeatman TJ, Kvols LK. Nasir A, et al. Among authors: kelley st. Cancer Control. 2006 Jan;13(1):52-60. doi: 10.1177/107327480601300108. Cancer Control. 2006. PMID: 16508627 Free article.

6

Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.

Meredith KL, Weber JM, Turaga KK, Siegel EM, McLoughlin J, Hoffe S, Marcovalerio M, Shah N, Kelley S, Karl R. Meredith KL, et al. Among authors: kelley s. Ann Surg Oncol. 2010 Apr;17(4):1159-67. doi: 10.1245/s10434-009-0862-1. Epub 2010 Feb 6. Ann Surg Oncol. 2010. PMID: 20140529

7

Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy.

Kelley ST, Coppola D, Karl RC. Kelley ST, et al. J Gastrointest Surg. 2004 Mar-Apr;8(3):227-31; discussion 231-2. doi: 10.1016/j.gassur.2003.11.024. J Gastrointest Surg. 2004. PMID: 15019913

8

Successful completion of neoadjuvant chemoradiation and surgical resection for esophageal cancer after perforation: a case for endoscopic stenting.

Hernandez JM, Barthel JS, Kelley ST. Hernandez JM, et al. Among authors: kelley st. Am Surg. 2008 Dec;74(12):1215-7. Am Surg. 2008. PMID: 19097541

9

Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.

Melis M, McLoughlin JM, Dean EM, Siegel EM, Weber JM, Shah N, Kelley ST, Karl RC. Melis M, et al. J Surg Res. 2009 May 1;153(1):114-20. doi: 10.1016/j.jss.2008.06.005. Epub 2008 Jul 31. J Surg Res. 2009. PMID: 19201421

10

Angiolipoma of the esophagus: a rare clinical dilemma.

Jensen EH, Klapman JB, Kelley ST. Jensen EH, et al. Among authors: kelley st. Dis Esophagus. 2006;19(3):203-7. doi: 10.1111/j.1442-2050.2006.00567.x. Dis Esophagus. 2006. PMID: 16723000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,302 results

Search Page

Filters